$VTGN
VistaGen Therapeutics Inc
PRICE
$0.15 ▲3.878%
Extented Hours
VOLUME
3,322,845
DAY RANGE
0.135 - 0.148
52 WEEK
0.0768 - 1.79
Key Metrics
Market Cap
30.46 M
Beta
1.78
Avg. Volume
4.52 M
Shares Outstanding
219.33 M
Yield
0%
Public Float
0
Next Earnings Date
2023-06-22
Next Dividend Date
Company Information
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets.
Website: www.vistagen.com
HQ: ,
Related News